Sign in

CIK 0001661181

  • Accelerated filer

Organogenesis Holdings Inc.

Sign in to watch
Ticker
ORGO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 781-575-0775
Business address
85 DAN ROAD, CANTON, MA, 02021
Former names
Avista Healthcare Public Acquisition Corp.
  1. 4 Exercise or conversion VP Health Policy & Contracting acquired 30,450 shares (option exercise)
  2. 4 Exercise or conversion Chief Commercial Officer acquired 1,817 shares (option exercise)
  3. 4 Open-market buy Director bought 542,349 shares at an average $3.98 ($2,160,957)
  4. 4 Exercise or conversion President and CEO acquired 397,900 shares (option exercise)
  5. 4 Open-market buy Director bought 6,000,000 shares at $5.00 ($30,000,000)
  6. 4 Open-market buy 10% owner bought 3,603 shares at $6.00 ($21,618)
  7. 4 Open-market buy Director bought 4,990 shares at an average $6.13 ($30,570)
  8. 4 Open-market buy Director bought 860,900 shares at an average $5.99 ($5,155,772)
  9. 4 Open-market buy Director bought 13,010 shares at an average $5.30 ($69,017)
  10. 4 Open-market buy Director bought 537,000 shares at an average $5.18 ($2,782,529)
  11. 4 Open-market buy Director bought 10,000 shares at $5.03 ($50,274)
  12. 4 Open-market buy Director bought 10,000 shares at $5.03 ($50,274)
  13. 4 Open-market buy Director bought 5,000 shares at $4.20 ($21,000)
  14. 4 Open-market buy Director bought 82,000 shares at an average $4.47 ($366,211)
  15. 4 Open-market buy 10% owner bought 10,000 shares at $4.50 ($44,975)
  16. 4 Open-market buy Director bought 105,100 shares at an average $4.50 ($473,209)
  17. 4 Open-market buy Director bought 105,100 shares at an average $4.50 ($473,209)
  18. 4 Open-market buy Director bought 577,600 shares at an average $4.84 ($2,797,551)
  19. 4 Grant or award Director acquired 389,501 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 13 of 17 · 321 filings